✦ LIBER ✦

Phase I, dose-finding study of AZD8931, an inhibitor of EGFR (erbB1), HER2 (erbB2) and HER3 (erbB3) signaling, in patients with advanced solid tumors

✍ Scribed by Tjulandin, S.; Moiseyenko, V.; Semiglazov, V.; Manikhas, G.; Learoyd, M.; Saunders, A.; Stuart, M.; Keilholz, U.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of EGFR, HER2 and HER3 signal

✍ Kurata, Takayasu; Tsurutani, Junji; Fujisaka, Yasuhito; Okamoto, Wataru; Hayashi 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 314 KB

Phase 1 and dose-finding study of patrit

✍ Wakui, Hiroshi; Yamamoto, Noboru; Nakamichi, Shinji; Tamura, Yousuke; Nokihara, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 341 KB

607 POSTER Impressive anti-tumor activit

✍ M. Beeram; J.S. De Bono; E.K. Rowinsky; P. O'Rourke; A. Ricart; L.A. Hammond; A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Phase I–IIa study of BMS-690514, an EGFR

✍ Soria, Jean-Charles; Baselga, José; Hanna, Nasser; Laurie, Scott A.; Bahleda, Ra 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 343 KB

A phase I dose escalation study of BIBW

✍ Eskens, F A L M; Mom, C H; Planting, A S T; Gietema, J A; Amelsberg, A; Huisman, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 173 KB

A phase 1 and dose-finding study of LY25

✍ Wakui, Hiroshi; Yamamoto, Noboru; Kitazono, Satoru; Mizugaki, Hidenori; Nakamich 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 366 KB